Policy / Pricing NHS risks missing out on independent prescriber benefits PharmaphorumGaps in support could undermine a wave of new independent prescribers entering the NHS and a push for more community-based care, warns a new report.Policy / PricingRead full story pharminent April 9, 2026 (Last updated: April 9, 2026) Pharmaphorum Gaps in support could undermine a wave of new independent prescribers entering the NHS and a push for more community-based care, warns a new report. Policy / PricingRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Novartis-backed Sidewinder collects $137M series B to strike at difficult-to-treat tumorsNext: Roche sticks with C4T, adding up to $1B for molecular glue partnership Related Stories Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026 Policy / Pricing UK commits to pharma IP protection in Swiss trade deal pharminent July 16, 2026 Policy / Pricing Germany approves healthcare costs overhaul despite significant pharma opposition pharminent July 13, 2026
